Research News

Revealing Mitochondrial Secret to Cancer Therapy Resistance

New, collaborative work from researchers’ team led by Dr. Shruti Bhatt at National University of Singapore and Dr. Letai at Dana-Farber Cancer Institute has succeeded in understanding the biology of relapsed cancer cells by using mouse models of acute myeloid leukemia (AML), highly aggressive blood cancer.

Read more here: https://aacrjournals.org/bloodcancerdiscov/article-abstract/doi/10.1158/2643-3230.BCD-24-0001/735047/Acquired-Multidrug-Resistance-in-AML-Is-Caused-by?redirectedFrom=fulltext

 

 

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Next-Generation Sequencing in Metastatic Breast Cancer: A Game Changer for Asian Patients

This study, led by N2CR members Dr Joline Lim and A/Prof David Tan, looks at the use of next-generation sequencing …

Read More →
Research News

Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

Cell cycle dysregulation, a key feature of cancer, leads to excessive cell division. CDK4 and CDK6 are essential for cell …

Read More →
Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. …

Read More →